As other major pharma players like Merck (NYSE:MRK) and Johnson & Johnson (NYSE:JNJ) vow to limit annual price hikes, a report by the Financial Times found that Pfizer (NYSE:PFE) has raised prices on 91 drugs by an average of 21% in 2017.
The most recent price hike at the start of June was the company’s 2nd for the year – they raised U.S. prices in January as well.
Get the full story at our sister site, Drug Delivery Business News.